We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$14.3B
AUM Growth
-$123M
Cap. Flow
+$2.4M
Cap. Flow %
0.02%
Top 10 Hldgs %
18.7%
Holding
394
New
12
Increased
127
Reduced
181
Closed
15

Top Buys

Rank Stock Value
1
SYY icon
Sysco
SYY
+$39.5M
2
STE icon
Steris
STE
+$39.5M
3
GPK icon
Graphic Packaging
GPK
+$36.3M
4
UFPT icon
UFP Technologies
UFPT
+$31.4M
5
ORCL icon
Oracle
ORCL
+$29.1M

Top Sells

Rank Stock Value
1
SFM icon
Sprouts Farmers Market
SFM
+$92M
2
ATR icon
AptarGroup
ATR
+$52.8M
3
SBUX icon
Starbucks
SBUX
+$49.2M
4
IDCC icon
InterDigital
IDCC
+$38.8M
5
CORT icon
Corcept Therapeutics
CORT
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 23.92%
2 Financials 16.3%
3 Healthcare 14.03%
4 Industrials 13.35%
5 Consumer Discretionary 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
326
Microchip Technology
MCHP
$40.3B
$406K ﹤0.01%
7,075
-225
-3% -$15.5K
VNQ icon
327
Vanguard Real Estate ETF
VNQ
$39.2B
$403K ﹤0.01%
4,522
QQQ icon
328
Invesco QQQ Trust
QQQ
$453B
$402K ﹤0.01%
787
GM icon
329
General Motors
GM
$80.4B
$399K ﹤0.01%
7,483
XYL icon
330
Xylem
XYL
$27.3B
$397K ﹤0.01%
3,418
TD icon
331
Toronto Dominion Bank
TD
$198B
$395K ﹤0.01%
7,425
-3,125
-30% -$175K
OTIS icon
332
Otis Worldwide
OTIS
$27.4B
$389K ﹤0.01%
4,198
T icon
333
AT&T
T
$159B
$386K ﹤0.01%
16,939
-230
-1% -$5.18K
PLD icon
334
Prologis
PLD
$135B
$376K ﹤0.01%
3,558
HIG icon
335
Hartford Financial Services
HIG
$38.9B
$372K ﹤0.01%
3,400
FIX icon
336
Comfort Systems
FIX
$60.9B
$371K ﹤0.01%
875
+254
+41% +$112K
MDY icon
337
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$367K ﹤0.01%
645
EG icon
338
Everest Group
EG
$14.5B
$362K ﹤0.01%
1,000
-31,886
-97% -$11.9M
AZN icon
339
AstraZeneca
AZN
$263B
$358K ﹤0.01%
2,736
-347
-11% -$48.6K
IJH icon
340
iShares Core S&P Mid-Cap ETF
IJH
$122B
$351K ﹤0.01%
5,635
WST icon
341
West Pharmaceutical
WST
$24B
$347K ﹤0.01%
1,060
-50
-5% -$15.7K
VRTX icon
342
Vertex Pharmaceuticals
VRTX
$121B
$326K ﹤0.01%
810
-150
-16% -$69.5K
VGT icon
343
Vanguard Information Technology ETF
VGT
$139B
$320K ﹤0.01%
4,120
DUK icon
344
Duke Energy
DUK
$97.8B
$314K ﹤0.01%
2,918
LRGF icon
345
iShares US Equity Factor ETF
LRGF
$3.58B
$309K ﹤0.01%
5,120
MS icon
346
Morgan Stanley
MS
$331B
$305K ﹤0.01%
2,423
BN icon
347
Brookfield
BN
$104B
$300K ﹤0.01%
7,821
+228
+3% +$8.59K
PAA icon
348
Plains All American Pipeline
PAA
$17.3B
$299K ﹤0.01%
17,500
-500
-3% -$8.7K
SJM icon
349
J.M. Smucker
SJM
$12.7B
$285K ﹤0.01%
2,585
-5,945
-70% -$684K
INGR icon
350
Ingredion
INGR
$6.27B
$279K ﹤0.01%
2,027

Similar funds

Boston Trust Walden's Q4 2024 Portfolio in Review

As of Q4 2024, Boston Trust Walden held 394 positions worth $14.3B, down 0.86% from $14.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q4 2024 filing shows 12 new, 127 increased, 181 reduced and 15 closed positions. Its largest new stake was Graphic Packaging: 1,256,679 shares worth $34.1M. The largest sale was Sprouts Farmers Market, an estimated $92M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q4 2024 buy was Graphic Packaging: 1,256,679 shares worth $34.1M.
  • Boston Trust Walden added most to Sysco in Q4 2024, an estimated $39.5M increase.
  • Boston Trust Walden's biggest Q4 2024 reduction was Sprouts Farmers Market, cutting an estimated $92M.
  • Boston Trust Walden fully exited Revvity in Q4 2024, selling an estimated $29.9M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $14.3B portfolio in Q4 2024.
  • Boston Trust Walden opened 12 new positions and closed 15 in Q4 2024.
  • Boston Trust Walden's portfolio value fell 0.86% quarter-over-quarter to $14.3B.

Based on Boston Trust Walden's 13F filing for Q4 2024, filed 24 Jan 2025.